Twist Bioscience TWST 深 沪
等待开盘 12-24 09:30:00 美东时间
33.84
-1.220
-3.48%
华盛通- 最 高34.90
- 今 开34.53
- 成交量 80.47万股
- 最 低 33.285
- 昨 收 35.06
- 总市值 20.69亿
- 52周最高 55.3325
- 市盈率 静 --
- 换手率 1.32%
- 52周最低 23.30
- 委 比 -24.03%
- 总股本 6114.80万
- 历史最高 214.07
- 量 比 0.53
- 振 幅 4.61%
- 历史最低 11.46
- 每 手 1
- 风险率 7.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aptamer Group Partners with Twist Bioscience for NGS Market Expansion
Aptamer Group Plc ( ($GB:APTA) ) has provided an update. Aptamer Group plc has ...
12-16 18:37
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
12-16 09:36
Barclays Maintains Overweight on Twist Bioscience, Raises Price Target to $39
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and raises the price target from $37 to $39.
12-16 05:11
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
11-18 15:28
Cathie Wood Bets Big On This Peter Thiel-Backed Coinbase Rival As Bitcoin Crashes Below $91,000
On Monday, Cathie Wood-led Ark Invest executed significant trades involving Bullish (NYSE:BLSH), Reddit Inc.
11-18 10:42
Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $37
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $40 to $37.
11-17 22:55
Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses
Twist Bioscience reports mixed Q4 earnings with a loss of 45 cents, sales of $99.01 million beating consensus.
11-15 00:29
Twist Bioscience Sees FY2026 Sales $425.000M-$435.000M vs $374.691M Est
Twist Bioscience (NASDAQ:TWST) sees FY2026 sales of $425.000 million-$435.000 million vs $374.691 million analyst estimate.
11-14 20:24
Twist Bioscience Q4 EPS $(0.45) Misses $(0.43) Estimate, Sales $99.009M Beat $97.317M Estimate
Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.43) by 4.65 percent. This is a 23.73 percent increase over losses of $(0.59) per share from
11-14 20:24
Earnings Scheduled For November 14, 2025
Companies Reporting Before The Bell • Inhibrx Biosciences (NASDAQ:INBX) is expe...
11-14 19:11
